FDA seeks to boost accuracy of blood-oxygen monitors across skin tones
The U.S. health regulator on Monday proposed new guidelines for widely-used blood oxygen monitoring devices to improve their performance across skin tones amid growing evidence that the current ones are not reliable for patients with darker skin.
FDA sets 1st voluntary limits on lead in children's food
The FDA will decide later this month whether to approve a novel drug for acute pain that could offer a nonaddictive ...
The Food and Drug Administration on Monday proposed a long-awaited plan aimed at improving how pulse oximeters work on people ...
You don't need a prescription to purchase a test that will tell you whether you're sick with COVID or the flu.
The snacks were distributed in the state of New York and have been recalled due to undeclared additives and flavor enhancers.
In recent years, the FDA has amped up its supervision of accelerated approvals, including by requiring that confirmatory ...
The U.S. health regulator on Monday proposed a new guidance for widely used blood oxygen monitoring devices to improve their ...
After nearly a decade of machine learning innovations, the FDA has issued its first draft guidance on the use of AI in drug ...
By the end of March, the regulator could clear a highly anticipated pain drug from Vertex and a heart drug that’s critical to Alnylam’s future.
Results that may be inaccessible to you are currently showing.
Hide inaccessible results
Feedback